Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Assets (2016 - 2025)

Historic Assets for Sunshine Biopharma (SBFM) over the last 14 years, with Q3 2025 value amounting to $31.5 million.

  • Sunshine Biopharma's Assets rose 475.95% to $31.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.5 million, marking a year-over-year increase of 475.95%. This contributed to the annual value of $30.6 million for FY2024, which is 1175.06% up from last year.
  • Latest data reveals that Sunshine Biopharma reported Assets of $31.5 million as of Q3 2025, which was up 475.95% from $32.0 million recorded in Q2 2025.
  • Sunshine Biopharma's Assets' 5-year high stood at $42.0 million during Q2 2022, with a 5-year trough of $1.8 million in Q2 2021.
  • In the last 5 years, Sunshine Biopharma's Assets had a median value of $29.2 million in 2025 and averaged $24.1 million.
  • As far as peak fluctuations go, Sunshine Biopharma's Assets skyrocketed by 281808.19% in 2021, and later tumbled by 3234.25% in 2023.
  • Sunshine Biopharma's Assets (Quarter) stood at $2.2 million in 2021, then soared by 1227.52% to $29.2 million in 2022, then dropped by 6.49% to $27.3 million in 2023, then rose by 11.75% to $30.6 million in 2024, then grew by 3.03% to $31.5 million in 2025.
  • Its Assets stands at $31.5 million for Q3 2025, versus $32.0 million for Q2 2025 and $29.2 million for Q1 2025.